Back to Search
Start Over
Update on Exhaled Nitric Oxide in Clinical Practice.
- Source :
- CHEST; May2016, Vol. 149 Issue 5, p1340-1344, 5p
- Publication Year :
- 2016
-
Abstract
- Asthma is characterized by chronic airway inflammation. Fractional exhaled nitric oxide (Feno) has emerged as a marker of T-helper cell type 2-mediated allergic airway inflammation. Recent studies suggest a role for Feno testing as a point-of-care tool in the management of patients with asthma. This Topics in Practice Management article reviews current coverage and reimbursement issues related to Feno testing and provides an overview of pertinent recent studies. [ABSTRACT FROM AUTHOR]
- Subjects :
- PHYSIOLOGICAL effects of nitric oxide
AIRWAY (Anatomy)
TH2 cells
POINT-of-care testing
ASTHMA treatment
HEALTH insurance
ADRENOCORTICAL hormones
HORMONE therapy
ASTHMA diagnosis
DRUG therapy for asthma
NITRIC oxide analysis
ASTHMA
BREATH tests
INFLAMMATION
INSURANCE
NITRIC oxide
T cells
HEALTH insurance reimbursement
INHALATION administration
Subjects
Details
- Language :
- English
- ISSN :
- 00123692
- Volume :
- 149
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- CHEST
- Publication Type :
- Academic Journal
- Accession number :
- 117161150
- Full Text :
- https://doi.org/10.1016/j.chest.2015.11.020